Swedencare AB Key Fundamental Indicators
| SWDCF Stock | USD 3.60 0.00 0.00% |
As of the 11th of February 2026, Swedencare has the Risk Adjusted Performance of (0.08), variance of 5.19, and Coefficient Of Variation of (941.85). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Swedencare AB, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down twelve technical drivers for Swedencare AB, which can be compared to its competition. Please validate Swedencare AB coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and value at risk to decide if Swedencare is priced more or less accurately, providing market reflects its prevalent price of 3.6 per share. Given that Swedencare AB has total risk alpha of (0.49), we advise you to double-check Swedencare AB's current market performance to make sure the company can sustain itself at a future point.
Swedencare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Swedencare's valuation are provided below:Swedencare AB does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Swedencare |
Swedencare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Swedencare's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Swedencare.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Swedencare on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Swedencare AB or generate 0.0% return on investment in Swedencare over 90 days. Swedencare is related to or competes with Elite Pharma, Basilea Pharmaceutica, Allergy Therapeutics, Viva Biotech, Glass House, and PolyNovo. Swedencare AB , together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products More
Swedencare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Swedencare's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Swedencare AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 14.48 | |||
| Value At Risk | (4.00) |
Swedencare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Swedencare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Swedencare's standard deviation. In reality, there are many statistical measures that can use Swedencare historical prices to predict the future Swedencare's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | 0.5436 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Swedencare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Swedencare February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 0.5536 | |||
| Mean Deviation | 0.8624 | |||
| Coefficient Of Variation | (941.85) | |||
| Standard Deviation | 2.28 | |||
| Variance | 5.19 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | 0.5436 | |||
| Maximum Drawdown | 14.48 | |||
| Value At Risk | (4.00) | |||
| Skewness | (2.88) | |||
| Kurtosis | 18.97 |
Swedencare AB Backtested Returns
Swedencare AB owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Swedencare AB exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Swedencare's Coefficient Of Variation of (941.85), variance of 5.19, and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide. The entity has a beta of -0.46, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Swedencare are expected to decrease at a much lower rate. During the bear market, Swedencare is likely to outperform the market. At this point, Swedencare AB has a negative expected return of -0.26%. Please make sure to validate Swedencare's information ratio, as well as the relationship between the value at risk and rate of daily change , to decide if Swedencare AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.05 |
Very weak reverse predictability
Swedencare AB has very weak reverse predictability. Overlapping area represents the amount of predictability between Swedencare time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Swedencare AB price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Swedencare price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Swedencare AB has a Return On Equity of 0.0284. This is 100.12% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 109.16% lower than that of the firm.
Swedencare AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Swedencare's current stock value. Our valuation model uses many indicators to compare Swedencare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Swedencare competition to find correlations between indicators driving Swedencare's intrinsic value. More Info.Swedencare AB is rated fifth in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Swedencare AB is roughly 3.51 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Swedencare's earnings, one of the primary drivers of an investment's value.Swedencare Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Swedencare's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Swedencare could also be used in its relative valuation, which is a method of valuing Swedencare by comparing valuation metrics of similar companies.Swedencare is currently under evaluation in return on equity category among its peers.
Swedencare Fundamentals
| Return On Equity | 0.0284 | |||
| Return On Asset | 0.0081 | |||
| Profit Margin | 0.09 % | |||
| Current Valuation | 793.04 M | |||
| Shares Outstanding | 158.73 M | |||
| Shares Owned By Insiders | 63.52 % | |||
| Shares Owned By Institutions | 24.78 % | |||
| Price To Earning | 55.56 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 3.57 X | |||
| Revenue | 770.44 M | |||
| Gross Profit | 388.64 M | |||
| EBITDA | 137.5 M | |||
| Net Income | 54.62 M | |||
| Total Debt | 616.97 M | |||
| Debt To Equity | 0.22 % | |||
| Current Ratio | 2.14 X | |||
| Cash Flow From Operations | 125.85 M | |||
| Earnings Per Share | 0.12 X | |||
| Number Of Employees | 506 | |||
| Beta | 1.11 | |||
| Market Capitalization | 522.57 M | |||
| Total Asset | 3.47 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 3.47 B |
About Swedencare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Swedencare AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Swedencare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Swedencare AB based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Swedencare AB , together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products. Swedencare AB was incorporated in 1993 and is headquartered in Malm, Sweden. Swedencare is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Swedencare OTC Stock
Swedencare financial ratios help investors to determine whether Swedencare OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Swedencare with respect to the benefits of owning Swedencare security.